Bio-Perspectives

Active

Private limited companyfounded 20233 yrs activeKroonlaan 378, 1050 Elsene, BelgiumKBO/BCE: BE 1000.325.168

Summary

Bio-Perspectives has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €168,178 and a net result of €79,613. Its solvency ranks better than 70% of 584 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch Report Compare

Bio-PerspectivesActiveChecked score 98/100

Risk analysis Report Compare

Activity

Research and development on biotechnology

NACE 72101NACE 72110

1 site

Size

€206,760total assets 2025

Equity: €168,178
Profit: €79,613

Turnover not published (abridged schema)

Financial health

98 Excellent Checked score 2025

Bankruptcy chance 12 m: < 0.1%

Structure

Accounts 37 d early

Why 98- Founded in 2023+ Liquidity: current ratio 5.35, cash €145,067+ Sector Scientific research and development (NACE 72)+ Equity €168,178 (81.3% of total assets)Show the evidence

Checked score

Score 2025

98 / 100

Excellent

Probability in this band: under 0.55%

Better than 86% of its sector peers (NACE 72, micro)

Performance against the sector, not lower risk

Every signal that weighs is under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 81.3% of total assets

Liquidity 95-3

short-term debt 18.7% · cash 70.2%

Profitability 100=

return on assets 38.5%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (930 companies)

Last 24 months 11-2024: 0.7% 12-2024: 0.7%▲ +3.1% vs 11-2024 01-2025: 0.8%▲ +5.7% vs 12-2024 02-2025: 0.8%▲ +5.4% vs 01-2025 03-2025: 0.9%▲ +12.8% vs 02-2025 04-2025: 0.9%● 0.0% vs 03-2025 05-2025: 1.0%▲ +11.4% vs 04-2025 06-2025: 1.1%▲ +2.1% vs 05-2025highest value 07-2025: 1.0%▼ -4.9% vs 06-2025 08-2025: 0.1%▼ -94.4% vs 07-2025 09-2025: 0.1%▲ +7.1% vs 08-2025 10-2025: 0.1%▼ -1.7% vs 09-2025 11-2025: 0.1%● 0.0% vs 10-2025 12-2025: 0.1%● 0.0% vs 11-2025 01-2026: 0.1%● 0.0% vs 12-2025 02-2026: 0.1%▲ +3.4% vs 01-2026 03-2026: 0.1%● 0.0% vs 02-2026 04-2026: 0.1%▲ +4.9% vs 03-2026 05-2026: 0.1%▲ +18.8% vs 04-2026 06-2026: 0.1%▼ -1.3% vs 05-2026 07-2026: < 0.1%▼ -44.0% vs 06-2026lowest value 08-2026: < 0.1%● 0.0% vs 07-2026lowest value 09-2026: < 0.1%● 0.0% vs 08-2026lowest value 10-2026: < 0.1%● 0.0% vs 09-2026lowest value

Liquidity: current ratio 5.35, cash €145,067 lowers the probability
Sector Scientific research and development (NACE 72) lowers the probability
Equity €168,178 (81.3% of total assets) lowers the probability
Founded in 2023 raises the probability for this profile

Credit up to €16,000 at 30 days acceptable

Liquidity ample (current ratio 5.35 against 7.69 in 2024; short-term debt: 18.7% and cash: 70.2% of total assets), and 18.7% of the assets are financed with debt.

How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 83%, liquidity 85%, profitability 90%, growth against the median 87%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Liquidity: current ratio 5.35, cash €145,067

In the bankruptcy model this factor lowers the probability.

NBB · annual accounts

Sector Scientific research and development (NACE 72)

In the bankruptcy model this factor lowers the probability.

KBO

Equity €168,178 (81.3% of total assets)

In the bankruptcy model this factor lowers the probability.

NBB · annual accounts

Founded in 2023

In the bankruptcy model this factor raises the probability for this profile.

KBO

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.

NBB · 2 filings

Deviation from the deadline

2025

37 d early

2024

6 d early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 22 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

03-10-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage